Capecitabine Orion 150 mg kalvopäällysteiset tabletit, Oxaliplatin Accord 5 mg/ml, infuusiokonsentraatti, liuosta varten. clinical trials

Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastases

This study, called SYNCOPE, looks at new ways to treat advanced bowel cancer (rectal cancer) to stop it from coming back. It uses special medicine combinations for people at high risk to improve their chances of staying cancer-free.